• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Oncopeptides - Articles and news items

Oncopeptides presents clinical results from Phase I/II study of melflufen and dexamethasone in patients with relapsed and relapsed refractory multiple myeloma

Industry news / 17 June 2015 / Victoria White

Oncopeptides has presented results from an ongoing study of melflufen with dexamethasone in patients with relapsed and relapsed refractory multiple myeloma…

 

Webinar: Understanding ISO Standards: ISO 14644-2:2015 Cleanroom MonitoringFIND OUT MORE
+ +